PHARMACYTE BIOTECH, INC. (PMCB) Gross Margin
- Gross margin · 12 months: Value (m); Formula and calculation Gross profit / revenue. Period ending 2026-07-31..
Gross margin
Overview →Financial period ending 2026-07-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | (m) | Gross profit / revenue. Period ending 2026-07-31. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | (m) | Gross Profit |
| Revenue | 0.00 USD | |
| Cost of products and services | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-07-31 | (m) | $0.00 | (m) | (m) |
| 2026-04-30 | (m) | $0.00 | (m) | (m) |
| 2026-01-31 | (m) | $0.00 | (m) | (m) |
| 2025-10-31 | (m) | $0.00 | (m) | (m) |
| 2025-07-31 | (m) | $0.00 | (m) | (m) |
| 2025-04-30 | (m) | $0.00 | (m) | (m) |
| 2025-01-31 | (m) | $0.00 | (m) | (m) |
| 2024-10-31 | (m) | $0.00 | (m) | (m) |
| 2024-07-31 | (m) | $0.00 | (m) | (m) |
| 2024-04-30 | (m) | $0.00 | (m) | (m) |
| 2024-01-31 | (m) | $0.00 | (m) | (m) |
| 2023-10-31 | (m) | $0.00 | (m) | (m) |
| 2023-07-31 | (m) | $0.00 | (m) | (m) |
| 2023-04-30 | (m) | $0.00 | (m) | (m) |
| 2023-01-31 | (m) | $0.00 | (m) | (m) |
| 2022-10-31 | (m) | $0.00 | (m) | (m) |
| 2022-07-31 | (m) | $0.00 | (m) | (m) |
| 2022-04-30 | (m) | $0.00 | (m) | (m) |
| 2022-01-31 | (m) | $0.00 | (m) | (m) |
| 2021-10-31 | (m) | $0.00 | (m) | (m) |
| 2021-07-31 | (m) | $0.00 | (m) | (m) |
| 2021-04-30 | (m) | $0.00 | (m) | (m) |
| 2021-01-31 | (m) | $0.00 | (m) | (m) |
| 2020-10-31 | (m) | $0.00 | (m) | (m) |
| 2020-07-31 | (m) | $0.00 | (m) | (m) |
| 2020-04-30 | (m) | $0.00 | (m) | (m) |
| 2020-01-31 | (m) | $0.00 | (m) | (m) |
| 2019-10-31 | (m) | $0.00 | (m) | (m) |
| 2019-07-31 | (m) | $0.00 | (m) | (m) |
| 2019-04-30 | (m) | $0.00 | (m) | (m) |
| 2019-01-31 | (m) | $0.00 | (m) | (m) |
| 2018-10-31 | (m) | $0.00 | (m) | (m) |
| 2018-07-31 | (m) | $0.00 | (m) | (m) |
| 2018-04-30 | (m) | $0.00 | (m) | (m) |
| 2018-01-31 | (m) | $0.00 | (m) | (m) |
| 2017-10-31 | (m) | $0.00 | (m) | (m) |
| 2017-07-31 | (m) | $0.00 | (m) | (m) |
| 2017-04-30 | $0.00 | $0.00 | (m) | (m) |
| 2017-01-31 | $0.00 | $0.00 | (m) | (m) |
| 2016-10-31 | $0.00 | $0.00 | (m) | (m) |
| 2016-07-31 | $0.00 | $0.00 | (m) | (m) |
| 2016-04-30 | $0.00 | $0.00 | (m) | (m) |
| 2016-01-31 | $0.00 | $0.00 | (m) | (m) |
| 2015-10-31 | $0.00 | $0.00 | (m) | (m) |
| 2015-07-31 | $0.00 | $0.00 | (m) | (m) |
| 2015-04-30 | $0.00 | $0.00 | (m) | (m) |
| 2015-01-31 | $0.00 | $0.00 | (m) | (m) |
| 2014-10-31 | $0.00 | $0.00 | (m) | (m) |
| 2014-07-31 | $0.00 | $0.00 | (m) | (m) |
| 2014-04-30 | $0.00 | $0.00 | (m) | (m) |
| 2014-01-31 | $0.00 | $0.00 | (m) | (m) |
| 2013-10-31 | $-753.00 | $-753.00 | (m) | 100.00% |
| 2013-07-31 | $-4.09K | $5.53K | (m) | -73.83% |
| 2013-04-30 | $2.54K | $12.16K | (m) | 20.89% |
| 2013-01-31 | $13.76K | $18.84K | (m) | 73.03% |
| 2012-10-31 | $32.57K | $39.87K | (m) | 81.71% |
| 2012-07-31 | $49.71K | $53.42K | (m) | 93.06% |
| 2012-04-30 | $47.17K | $66.56K | (m) | 70.88% |
| 2012-01-31 | (m) | (m) | (m) | (m) |
| 2011-10-31 | (m) | (m) | (m) | (m) |
| 2011-07-31 | (m) | (m) | (m) | (m) |
| 2011-04-30 | $93.89K | (m) | (m) | (m) |
| 2011-01-31 | (m) | (m) | (m) | (m) |
| 2010-10-31 | (m) | (m) | (m) | (m) |
| 2010-07-31 | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |